Skip to content

The Siesta Group North America

Country not established

Devices
1

What The Siesta Group North America makes

The Siesta Group North America manufactures the SOMNOLYZER 24X7, a device designed for continuous monitoring of sleep patterns and respiratory activity, likely intended for clinical or home use.

The SOMNOLYZER 24X7 is classified as a Class II medical device in the US and is listed under the FDA’s 510(k) premarket notification process. The company is based in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Somnolyzer 24X7 Ref K083620

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does The Siesta Group North America have in the registry?

The registry currently lists 1 device for The Siesta Group North America. Devices recorded under merged duplicate company entries are counted once.

Which registries list The Siesta Group North America's devices?

Among its 1 most recently registered device, The Siesta Group North America has devices listed in FDA 510(k) (1 device).

What risk classes do The Siesta Group North America's devices fall under?

Among its 1 most recently registered device, the classes recorded for The Siesta Group North America's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from The Siesta Group North America in the registry?

The most recently registered devices listed for The Siesta Group North America include SOMNOLYZER 24X7.

Generated automatically from registry data and not verified by a human reviewer.